Segment Information - Segment Revenue, Operating loss and Depreciation and Amortization (Detail) - USD ($) $ in Thousands	3 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Segment Reporting Information [Line Items]
Revenue	$ 30,552	$ 24,933
Total operating loss	(322)	(7,229)
Depreciation and amortization	2,333	2,122
Operating Segments [Member]
Segment Reporting Information [Line Items]
Revenue	30,552	24,933
Total operating loss	2,900	(4,287)
Operating Segments [Member] | Medical Device [Member]
Segment Reporting Information [Line Items]
Revenue	23,545	19,018
Total operating loss	(224)	(7,235)
Depreciation and amortization	2,054	1,953
Operating Segments [Member] | In Vitro Diagnostics [Member]
Segment Reporting Information [Line Items]
Revenue	7,007	5,915
Total operating loss	3,124	2,948
Depreciation and amortization	97	77
Corporate Non Segment [Member]
Segment Reporting Information [Line Items]
Total operating loss	(3,222)	(2,942)
Depreciation and amortization	$ 182	$ 92